Avian flu vaccine stockpiling continues

Johnsen, Michael
November 2005
Drug Store News;11/7/2005, Vol. 27 Issue 15, p4
Trade Publication
The article focuses on the stockpiling of avian flu vaccines in the United States. The federal government and the global pharmaceutical community is increasing its efforts to prepare for potential avian flu pandemic. The United States Food and Drug Administration has formed a rapid response team to deal with a possible pandemic.


Related Articles

  • FDA Approves First US Avian Influenza Virus Vaccine.  // Pulmonary Reviews;May2007, Vol. 12 Issue 5, p14 

    The article reports on the approval of the first avian influenza virus vaccine for humans by the U.S. Food and Drug Administration. The vaccine manufactured by Sanofi Pasteur Inc. was obtained from a human strain and is intended for immunizing people 18 through 64 years of age at risk of...

  • Is Longer Always Better?  // Hastings Center Report;May/Jun2008, Vol. 38 Issue 3, p10 

    The article describes a case study aimed at developing a new treatment for avian influenza. The goal is to find ways of generating and collecting viral antibodies from the blood of healthy subjects after injecting them with an avian flu vaccine approved by the U.S. Food & Drug Administration....

  • MEDICINE IN THE NEWS. Asch-Goodkin, Judith; Kaplan, Deborah // Patient Care for the Nurse Practitioner;May2007, Vol. 10 Issue 5, p4 

    This section offers medical news briefs in the United States. The Infectious Diseases Society of America (IDSA) has issued new guidelines based on recent studies of travel-related illnesses. The U.S. Food and Drug Administration (FDA) has approved the bird flu vaccine to protect humans against...

  • U.S. vaccine against bird flu approved.  // Nation's Health;Jun/Jul2007, Vol. 37 Issue 5, p8 

    The article reports on the approval by the U.S. Food and Drug Administration (FDA) of the first vaccine against the H5N1 avian influenza virus in the country, manufactured by Sanofi Pasteur Inc. According to a clinical trial, fewer than half of the people vaccinated developed a protective level...

  • FDA Approves Sanofi Bird Flu Vaccine.  // Clinical Infectious Diseases;6/15/2007, Vol. 44 Issue 12, piv 

    The article reports on the approval of Food and Drug Administration (FDA) officials to a Sanofi-Aventis vaccine to prevent people from becoming infected with the H5NI bird flu virus in the U.S. On April 17, 2007, the U.S. health officials has approved the Sanofi bird flu vaccine after they have...

  • IN BRIEF.  // BMJ: British Medical Journal (International Edition);4/28/2007, Vol. 334 Issue 7599, p868 

    This article presents medical news briefs. The United States Food and Drug Administration has approved a human vaccine against the H5N1 influenza virus (bird flu). Medical Research Scotland is inviting applications for research projects on pain relief. Public prosecutors in the Netherlands have...

  • Pugh's view.  // Pulse;10/12/2006, Vol. 66 Issue 38, p9 

    A cartoon on bird flu vaccination of general practitioners is presented.

  • Iowa firm gets OK to make vaccine.  // Wallaces Farmer;Oct2015, Vol. 140 Issue 10, p66 

    The article informs that Harrisvaccines Inc., a company from Iowa, has received conditional approval from the U.S. Department of Agriculture (USDA) to manufacture avian influenza vaccine to prevent poultry from dying from the deadly avian influenza virus.

  • Avian Influenza Vaccine Licensed. CLAYTON, CHRIS // Progressive Farmer;Nov2015, Vol. 130 Issue 12, pPF-19 

    The article focuses on the conditional approval received by biotechnology company Harrisvaccines for production of vaccine for for bird flu.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics